Thomas C. Marbury
Orlando Clinical Research Center
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Thomas C. Marbury as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 09:17 UTC. Open this list on ClinicalTrials.gov
- Ph1NCT06845813 · Study to Investigate the Effect of Renal Impairment on the Pharmacokinetics, Safety, and Tolerability of AZD6234AstraZeneca · completed · Renal Impairment
- Ph1NCT06388616 · Study to Investigate the Effect of Hepatic Impairment on the Pharmacokinetics, Safety, and Tolerability of BalcinrenoneAstraZeneca · completed · Hepatic Impairment
- Ph1NCT06084104 · DZD9008 PK Study in Hepatic Impairment SubjectsDizal Pharmaceuticals · completed · Hepatic Impairment
- Ph1NCT05283746 · A Study of Epetraborole Tablets in Subjects With Degrees of Renal FunctionAN2 Therapeutics, Inc · completed · Renal Insufficiency
- Ph1NCT03401528 · A Phase 1 AVB-S6-500 Safety and Tolerability StudyAravive, Inc. · completed · Healthy Volunteer
- Ph1NCT02063230 · To Assess the Pharmacokinetics, Safety and Tolerability of Selumetinib in Patients With Hepatic Impairment and Healthy SubjectsAstraZeneca · completed · Solid Tumors
- Ph1NCT02063204 · To Assess the Pharmacokinetics, Safety and Tolerability of Selumetinib in Renal Impaired Subjects and Healthy SubjectsAstraZeneca · completed · Solid Tumours
- Ph1NCT00728689 · Phase I Trial of an Investigational Small Pox MedicationSIGA Technologies · completed · Orthopoxviral Disease, Smallpox, Monkey Pox
- Ph1/Ph2NCT00550849 · Study to Assess the Safety, Tolerability, and Pharmacodynamics of RTA 402 in Patients With Hepatic DysfunctionBiogen · terminated · Liver Disease · principal investigator
- Ph1NCT00546650 · Phase I Study to Compare NP101(Sumatriptan Iontophoretic Transdermal Patch) With Three Formulations of Imitrex®NuPathe Inc. · completed · Healthy
- Ph1NCT00431951 · Phase I, Escalating, Multiple-Dose, ST-246 Safety, Tolerability and Pharmacokinetics 21-Day Trial in Healthy VolunteersSIGA Technologies · completed · Healthy
Grants
NIH projects from RePORTER, fetched 2026-11-12 09:17 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 09:17 UTC. The ranking covers the 200 most relevant of 73 PubMed records, and a shared surname and initials can bring in a namesake. All 73 on PubMed
- Anaritide in acute tubular necrosis. Auriculin Anaritide Acute Renal Failure Study Group.N Engl J Med · 1997298 citationsRCR 9.4
- Pharmacokinetics, pharmacodynamics, and safety of apixaban in subjects with end-stage renal disease on hemodialysis.J Clin Pharmacol · 2016228 citationsRCR 9.7
- Comparative efficacy of olmesartan, losartan, valsartan, and irbesartan in the control of essential hypertension.J Clin Hypertens (Greenwich) · 2001196 citationsRCR 5.6
- Atrial natriuretic factor in oliguric acute renal failure. Anaritide Acute Renal Failure Study Group.Am J Kidney Dis · 2000157 citationsRCR 4.5
- 157 citationsRCR 4.5
- Pharmacokinetics of micafungin in healthy volunteers, volunteers with moderate liver disease, and volunteers with renal dysfunction.J Clin Pharmacol · 2005134 citationsRCR 4.6
- Effect of rifampin, a potent inducer of drug-metabolizing enzymes, on the pharmacokinetics of raltegravir.Antimicrob Agents Chemother · 2009132 citationsRCR 4.1
- Pharmacokinetics and Tolerability of a Single Dose of Semaglutide, a Human Glucagon-Like Peptide-1 Analog, in Subjects With and Without Renal Impairment.Clin Pharmacokinet · 2017105 citationsRCR 4.2
- Pharmacokinetics of repaglinide in subjects with renal impairment.Clin Pharmacol Ther · 200083 citationsRCR 2.3
- A double-blind randomized comparison of meal-related glycemic control by repaglinide and glyburide in well-controlled type 2 diabetic patients.Diabetes Care · 199975 citationsRCR 2.2